A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer.
Oral Oncol
; 43(2): 137-42, 2007 Feb.
Article
in En
| MEDLINE
| ID: mdl-16798061
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Radiation Injuries
/
Salivary Glands
/
Xerostomia
/
Bethanechol
/
Head and Neck Neoplasms
Type of study:
Clinical_trials
/
Etiology_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Oral Oncol
Journal subject:
NEOPLASIAS
Year:
2007
Document type:
Article
Affiliation country:
Brazil